Načítá se...
A novel statistical test for treatment differences in clinical trials using a response-adaptive forward-looking Gittins Index Rule
The most common objective for response-adaptive clinical trials is to seek to ensure that patients within a trial have a high chance of receiving the best treatment available by altering the chance of allocation on the basis of accumulating data. Approaches that yield good patient benefit properties...
Uloženo v:
| Vydáno v: | Biometrics |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7614356/ https://ncbi.nlm.nih.gov/pubmed/34669968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/biom.13581 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|